Pharmacokinetics of Glecaprevir/Pibrentasvir in children with chronic HCV infection: interim analysis of part 2 of the Dora study

Jonas, Maureen M.; Lon, Hoi Kei; Rhee,Susan; Gilmour, Susan M; Gonzalez-Peralta, Regino P.; Leung, Daniel H.; Ling, Simon C.; Lobritto, Steven; Narkewicz, Michael R; Sabharwai, Vishakha; Del Valle-Segarra, Antonio; Sinisi Lovell, Sandra; Porcalla, Ariel; Tripath, Rakesh; Sokal, Etienne

Pharmacokinetics of Glecaprevir/Pibrentasvir in children with chronic HCV infection: interim analysis of part 2 of the Dora study

Jonas, Maureen M.

;

Lon, Hoi Kei

;

Rhee,Susan

;

Gilmour, Susan M

;

Sokal, Etienne

;et.al.

(2019) The Liver Meeting AASLD (American Association of the Study of Liver Diseases) — Location: Boston, USA (8.November.2019)

Files

ABSTRACT1551.pdf

Open Access
Adobe PDF
349.05 KB

Download

Details

Authors

Jonas, Maureen M.Boston Children's Hospital
Author
Lon, Hoi KeiAbbvie
Author
Rhee,SusanAbbvie
Author
Gilmour, Susan MSollery Children's Hospital, Alberta, Canada
Author
Sokal, EtienneUCLouvain
Author

Affiliations

Citations

APA
Chicago
FWB

Jonas, M. M., Lon, H. K., Rhee, S., Gilmour, S. M., Gonzalez-Peralta, R. P., Leung, D. H., Ling, S. C., Lobritto, S., Narkewicz, M. R., Sabharwai, V., Del Valle-Segarra, A., Sinisi Lovell, S., Porcalla, A., Tripath, R., & Sokal, E. (2019). Pharmacokinetics of Glecaprevir/Pibrentasvir in children with chronic HCV infection: interim analysis of part 2 of the Dora study. Hepatology, November, Abstract 1551. https://hdl.handle.net/2078.5/124764 (Original work published 2019)